|
Variable
|
N
|
OS (months)
|
PFS (months)
|
|---|
|
Median
|
95%CI
|
Median
|
95%CI
|
|---|
|
Before PSM
| | | | | |
|
AS
|
62
|
13.27
|
11.35–15.19
|
10.07
|
8.40–12.09
|
|
SOX
|
81
|
11.17
|
9.61–12.72
|
6.70
|
5.51–7.89
|
|
AS (non-intestinal)
|
58
|
13.27
|
11.46–15.09
|
10.07
|
8.12–12.02
|
|
SOX (non-intestinal)
|
55
|
9.90
|
7.71–12.09
|
6.53
|
4.31–8.76
|
|
AS (diffuse)
|
42
|
14.23
|
11.70–16.77
|
10.07
|
7.81–12.33
|
|
SOX (diffuse)
|
35
|
8.83
|
6.67–11.00
|
4.60
|
3.54–5.66
|
|
After PSM
| | | | | |
|
AS
|
54
|
14.13
|
11.96–16.31
|
10.30
|
7.06–13.54
|
|
SOX
|
54
|
11.17
|
9.09–13.24
|
6.70
|
6.08–7.33
|
|
AS (non-intestinal)
|
50
|
14.23
|
12.14–16.33
|
10.30
|
7.53–13.07
|
|
SOX (non-intestinal)
|
39
|
9.90
|
7.30–12.50
|
6.87
|
5.26–8.48
|
|
AS (diffuse)
|
34
|
15.93
|
13.58–18.28
|
10.30
|
7.27–13.33
|
|
SOX (diffuse)
|
24
|
8.83
|
6.51–11.15
|
4.60
|
2.25–6.95
|
- OS, overall survival time; PFS, progress free survival time; CI, confidence intervals; non-intestinal, including diffuse lauren type and mixed lauren type; PSM, propensity score matching; N, number
